Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $51.56 million. The enterprise value is $51.55 million.
| Market Cap | 51.56M |
| Enterprise Value | 51.55M |
Important Dates
The last earnings date was Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBO has 107.82 million shares outstanding. The number of shares has increased by 571.61% in one year.
| Current Share Class | 107.82M |
| Shares Outstanding | 107.82M |
| Shares Change (YoY) | +571.61% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 2.78% |
| Owned by Institutions (%) | 3.56% |
| Float | 11.49M |
Valuation Ratios
The trailing PE ratio is 94.04.
| PE Ratio | 94.04 |
| Forward PE | n/a |
| PS Ratio | 1,520.90 |
| Forward PS | n/a |
| PB Ratio | 4.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 67.28 |
| EV / Sales | 1,520.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.45 |
Financial Efficiency
Return on equity (ROE) is 23.46% and return on invested capital (ROIC) is -21.97%.
| Return on Equity (ROE) | 23.46% |
| Return on Assets (ROA) | -17.79% |
| Return on Invested Capital (ROIC) | -21.97% |
| Return on Capital Employed (ROCE) | -34.66% |
| Weighted Average Cost of Capital (WACC) | 19.41% |
| Revenue Per Employee | $17,500 |
| Profits Per Employee | $395,500 |
| Employee Count | 2 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | -2.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.33% in the last 52 weeks. The beta is 2.76, so IBO's price volatility has been higher than the market average.
| Beta (5Y) | 2.76 |
| 52-Week Price Change | -19.33% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 55.57 |
| Average Volume (20 Days) | 242,576 |
Short Selling Information
The latest short interest is 546,651, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 546,651 |
| Short Previous Month | 557,404 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 4.76% |
| Short Ratio (days to cover) | 17.87 |
Income Statement
In the last 12 months, IBO had revenue of $35,000 and earned $791,000 in profits. Earnings per share was $0.01.
| Revenue | 35,000 |
| Gross Profit | -389,000 |
| Operating Income | -5.10M |
| Pretax Income | -1.80M |
| Net Income | 791,000 |
| EBITDA | -3.95M |
| EBIT | -5.10M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $10,000 in cash and no debt, with a net cash position of $10,000 or $0.00 per share.
| Cash & Cash Equivalents | 10,000 |
| Total Debt | n/a |
| Net Cash | 10,000 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 14.01M |
| Book Value Per Share | 0.10 |
| Working Capital | -1.73M |
Cash Flow
| Operating Cash Flow | -508,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | -109,000 |
| Free Cash Flow | -508,000 |
| FCF Per Share | -$0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | -14,557.14% |
| Pretax Margin | -5,148.57% |
| Profit Margin | 2,260.00% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -571.61% |
| Shareholder Yield | -571.61% |
| Earnings Yield | 1.49% |
| FCF Yield | -0.95% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IBO has an Altman Z-Score of 3 and a Piotroski F-Score of 2.
| Altman Z-Score | 3 |
| Piotroski F-Score | 2 |